Today: 4 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

TNXP Stock Today, 7 December 2025: Price, Latest News and 2026 Forecasts for Tonix Pharmaceuticals

TNXP Stock Today, 7 December 2025: Price, Latest News and 2026 Forecasts for Tonix Pharmaceuticals

Tonix Pharmaceuticals’ stock surged over 10,000% in the past year after FDA approval and U.S. launch of its fibromyalgia drug Tonmya, the first new therapy for the condition in over 15 years. TNXP closed at $19.64 on December 5, with a market cap near $200 million and high volatility. Short interest stands at 16.5%. The company is also testing the drug for major depressive disorder.
Dutch Bros (BROS) Stock Outlook 2026: Latest News, Price Targets, and Growth Risks as of December 7, 2025

Dutch Bros (BROS) Stock Outlook 2026: Latest News, Price Targets, and Growth Risks as of December 7, 2025

Dutch Bros shares closed at $58.43 on December 5, 2025, down 4% for the day but up 12% over the past month and 13% over the year. The company reported Q3 revenue of $423.6 million, up 25% year-over-year, and raised full-year guidance. Analysts lifted price targets to $70–$80+, while institutional buyers and insiders traded heavily. Valuation remains high, with a P/E ratio near 117.
7 December 2025
Kroger (KR) Stock Update: Earnings Shock, E‑Commerce Pivot and Fresh Price Targets – December 7, 2025

Kroger (KR) Stock Update: Earnings Shock, E‑Commerce Pivot and Fresh Price Targets – December 7, 2025

Kroger reported a $1.54 billion operating loss for Q3 2025 after a $2.6 billion e-commerce impairment, but adjusted EPS beat forecasts at $1.05. Shares fell to $62.71, down from early December highs. Revenue missed estimates, while gross margin and digital sales improved. Wall Street targets still imply double-digit upside.
Spotify (SPOT) Stock on December 7, 2025: Leadership Shake-Up, High Valuation and 2026 Forecasts

Spotify (SPOT) Stock on December 7, 2025: Leadership Shake-Up, High Valuation and 2026 Forecasts

Spotify shares closed near $565 on December 7, 2025, down about 23% from pre-CEO transition levels but still up year-to-date. The stock’s pullback followed news that founder Daniel Ek will become executive chairman, with Gustav Söderström and Alex Norström set to take over as co-CEOs on January 1. Trading has been volatile amid strong user growth and new product launches.
7 December 2025
VGT Stock Today: Vanguard Information Technology ETF Near Record Highs as Big Tech Dominance Sparks Debate (December 7, 2025)

VGT Stock Today: Vanguard Information Technology ETF Near Record Highs as Big Tech Dominance Sparks Debate (December 7, 2025)

The Vanguard Information Technology ETF (VGT) closed at $767.97 on December 5, near its all-time high, after gaining 19% over the past year. Nvidia, Apple, and Microsoft now make up about 45% of VGT’s value. The fund manages roughly $113 billion in assets and charges a 0.09% expense ratio. Recent commentary highlights both concentration risks and VGT’s strong performance versus other tech ETFs.
SQQQ Stock Outlook Today (December 7, 2025): Is the 3x Inverse Nasdaq ETF Running Out of Steam?

SQQQ Stock Outlook Today (December 7, 2025): Is the 3x Inverse Nasdaq ETF Running Out of Steam?

ProShares UltraPro Short QQQ (SQQQ) closed at $66.49 on December 5, down 1.14%, capping an eight-loss streak in ten sessions and a 17.8% drop over two weeks. Assets under management remain near $2.5 billion, with daily volume above 30 million shares. SQQQ’s one-year total return stands near –56%, with technical signals flashing “sell” and volatility exceeding 50%.
7 December 2025
TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally?

TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally?

Direxion Daily TSLA Bull 2X Shares ETF (TSLL) surged about 30% in two weeks, trading near $20.60 as of December 7, 2025, with gains in 8 of the last 10 sessions. Despite the rally, TSLL remains down roughly 30% year-to-date and far below its 52-week high of $40.57. Assets under management stand near $7 billion, with average daily volume around 134 million shares.
7 December 2025
Lowe’s (LOW) Stock Outlook for 2026: Can a Dividend King Win After the FBM Mega‑Deal and Forecast Cut?

Lowe’s (LOW) Stock Outlook for 2026: Can a Dividend King Win After the FBM Mega‑Deal and Forecast Cut?

Lowe’s shares closed at $248.47 on December 5, 2025, near the middle of their 52-week range, with a market cap of $139.4 billion. The stock is down double digits over the past year despite beating Q2 earnings estimates and closing an $8.8 billion acquisition. 2025 guidance remains cautious, citing weak demand for big-ticket home projects. The S&P 500 is up over 13% in the same period.
7 December 2025
NCLH Stock in December 2025: Can Norwegian Cruise Line’s Cheap Valuation Outrun Caribbean Risks?

NCLH Stock in December 2025: Can Norwegian Cruise Line’s Cheap Valuation Outrun Caribbean Risks?

Norwegian Cruise Line Holdings reported record Q3 2025 revenue and profits, raising full-year EPS guidance to $2.10. Despite this, NCLH shares closed at $18.92 on Dec. 5, down 32% over the past year and 36% below their 52-week high. The stock dropped nearly 10% after Q3 results missed analyst revenue and Q4 EPS estimates. NCLH trades at a steep discount to industry valuation metrics.
7 December 2025
RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

Red Cat Holdings closed at $8.02 on December 5, 2025, valuing the company at about $957 million, roughly 52% below its October high. Shares jumped nearly 9% after Red Cat named a new CFO and promoted its CFO to COO on December 2. Trading volume was about half the daily average. The stock remains volatile, sitting 75% above its 52-week low but still down 5% year-over-year.
RXRX Stock Today: Insider Selling, CEO Transition and Trial Catalyst Shape Recursion Pharmaceuticals’ Outlook (December 2025)

RXRX Stock Today: Insider Selling, CEO Transition and Trial Catalyst Shape Recursion Pharmaceuticals’ Outlook (December 2025)

Recursion Pharmaceuticals shares closed at $4.71 on December 5, 2025, near the bottom of their 52-week range, with market cap at $2.46 billion. CEO Christopher Gibson and co-founder Blake Borgeson sold shares in early December. The company will present clinical data for its lead asset REC-4881 on December 8. Najat Khan is set to become CEO on January 1, 2026.
7 December 2025
Nu Holdings (NU) Stock Outlook: Banking License Pivot, Q3 2025 Earnings Beat and Fresh Analyst Targets

Nu Holdings (NU) Stock Outlook: Banking License Pivot, Q3 2025 Earnings Beat and Fresh Analyst Targets

Nu Holdings shares closed at $16.70 on December 6 after a 5% drop, but remain near 52-week highs and up 50–70% year-to-date. Q3 2025 results showed record revenue of $4.2 billion and net income of $783 million, both up 39% year-over-year. Nubank plans to seek a full banking license in Brazil amid new regulations. Trading volumes surged as volatility and regulatory concerns drew short-term attention.
7 December 2025
REIT Stock Prices on December 7, 2025: Are Rate Cuts Setting Up a 2026 Rally?

REIT Stock Prices on December 7, 2025: Are Rate Cuts Setting Up a 2026 Rally?

The FTSE Nareit All REITs Index slipped 0.11% on December 5, while the Mortgage REITs Index rose 0.38%. The Vanguard Real Estate ETF closed at $89.88, down 6% over the past year. Listed REITs show higher or equal occupancy rates than private funds in most sectors, but trade at cheaper valuations. The valuation gap between REITs and the S&P 500 has widened to levels last seen during major market shocks.
Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

Walgreens Boots Alliance was taken private by Sycamore Partners on August 28, 2025, and its WBA shares were delisted from Nasdaq. Shareholders received $11.45 per share in cash plus a right tied to VillageMD asset sales. The last trading price was about $11.98. Recent headlines focus on a December 3 data breach and real estate moves, but WBA stock no longer trades.
CRWD Stock Forecast: Can CrowdStrike’s AI Security Machine Justify Its Sky‑High Valuation in 2026?

CRWD Stock Forecast: Can CrowdStrike’s AI Security Machine Justify Its Sky‑High Valuation in 2026?

CrowdStrike closed near $512 per share before the weekend of December 7, 2025, valuing the company at about $128 billion. Shares are up roughly 50% over the past year, with the stock less than 10% below its 52-week high. Q3 revenue rose 22% to $1.23 billion, beating expectations, while net new annual recurring revenue jumped 73% year over year. Wall Street’s 12-month price targets range widely, with a median near $572.
7 December 2025
1 516 517 518 519 520 584
Go toTop